Онлайн
библиотека книг
Книги онлайн » Медицина » Живи долго! Научный подход к долгой молодости и здоровью - Майкл Грегер

Шрифт:

-
+

Закладка:

Сделать
1 ... 306 307 308 309 310 311 312 313 314 ... 510
Перейти на страницу:
on Astragali radix: implications for Astragali radix as a personalized medicine. Int J Mol Sci. 2019;20(6):1463. https://pubmed.ncbi.nlm.nih.gov/30909474/

2102

Liu P, Zhao H, Luo Y. Anti-aging implications of Astragalus membranaceus (Huangqi): a well-known Chinese tonic. Aging Dis. 2017;8(6):868–86. https://pubmed.ncbi.nlm.nih.gov/29344421/

2103

Fauce SR, Jamieson BD, Chin AC, et al. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol. 2008;181(10):7400–6. https://pubmed.ncbi.nlm.nih.gov/18981163/

2104

Dow CT, Harley CB. Evaluation of an oral telomerase activator for early age-related macular degeneration – a pilot study. Clin Ophthalmol. 2016;10:243–9. https://pubmed.ncbi.nlm.nih.gov/26869760/

2105

United States of America before the Federal Trade Commission in the matter of Telomerase Activation Sciences, Inc., and Noel Thomas Patton. Docket No. C-4644. FTC.gov. https://www.ftc.gov/system/files/documents/cases/142_3103_-_telomerase_complaint_final.pdf. Updated April 19, 2018. Accessed December10, 2021.; https://www.ftc.gov/system/files/documents/cases/142_3103_-_telomerase_complaint_final.pdf

2106

Tsoukalas D, Fragkiadaki P, Docea AO, et al. Discovery of potent telomerase activators: unfolding new therapeutic and anti-aging perspectives. Mol Med Rep. 2019;20(4):3701–8. https://pubmed.ncbi.nlm.nih.gov/31485647/

2107

Tsoukalas D, Fragkiadaki P, Docea AO, et al. Discovery of potent telomerase activators: unfolding new therapeutic and anti-aging perspectives. Mol Med Rep. 2019;20(4):3701–8. https://pubmed.ncbi.nlm.nih.gov/31485647/

2108

Chandrika UG, Kumara PAASP. Gotu kola (Centella asiatica): nutritional properties and plausible health benefits. Adv Food Nutr Res. 2015;76:125–57. https://pubmed.ncbi.nlm.nih.gov/26602573/

2109

Tsoukalas D, Fragkiadaki P, Docea AO, et al. Discovery of potent telomerase activators: unfolding new therapeutic and anti-aging perspectives. Mol Med Rep. 2019;20(4):3701–8. https://pubmed.ncbi.nlm.nih.gov/31485647/

2110

Puttarak P, Dilokthornsakul P, Saokaew S, et al. Effects of Centella asiatica (L.) Urb. on cognitive function and mood related outcomes: a systematic review and meta-analysis. Sci Rep. 2017;7(1):10646. https://pubmed.ncbi.nlm.nih.gov/28878245/

2111

Larrick JW, Mendelsohn AR. Telomerase redux: ready for prime time? Rejuvenation Res. 2015;18(2):185–7. https://pubmed.ncbi.nlm.nih.gov/25790341/

2112

Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011;14(1):28–34. https://pubmed.ncbi.nlm.nih.gov/21102320/

2113

Prieto-Oliveira P. Telomerase activation in the treatment of aging or degenerative diseases: a systematic review. Mol Cell Biochem. 2021;476(2):599–607. https://pubmed.ncbi.nlm.nih.gov/33001374/

2114

Artandi SE, Depinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010;31(1):9–18. https://pubmed.ncbi.nlm.nih.gov/19887512/

2115

Ornish D, Weidner G, Fair WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174(3):1065–70. https://pubmed.ncbi.nlm.nih.gov/16094059/

2116

Skordalakes E. Telomerase and the benefits of healthy living. Lancet Oncol. 2008;9(11):1023–4. https://pubmed.ncbi.nlm.nih.gov/19012852/

2117

Huzen J, Wong LS, van Veldhuisen DJ, et al. Telomere length loss due to smoking and metabolic traits. J Intern Med. 2014;275(2):155–63. https://pubmed.ncbi.nlm.nih.gov/24118582/

2118

García-Calzón S, Moleres A, Martínez-González MA, et al. Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population. Clin Nutr. 2015;34(4):694–9. https://pubmed.ncbi.nlm.nih.gov/25131600/

2119

Leung CW, Laraia BA, Needham BL, et al. Soda and cell aging: associations between sugar-sweetened beverage consumption and leukocyte telomere length in healthy adults from the National Health and Nutrition Examination Surveys. Am J Public Health. 2014;104(12):2425–31. https://pubmed.ncbi.nlm.nih.gov/25322305/

2120

Nettleton JA, Diez-Roux A, Jenny NS, Fitzpatrick AL, Jacobs DR. Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2008;88(5):1405–12. https://pubmed.ncbi.nlm.nih.gov/18996878/

2121

Gu Y, Honig LS, Schupf N, et al. Mediterranean diet and leukocyte telomere length in a multi-ethnic elderly population. Age (Dordr). 2015;37(2):9758. https://pubmed.ncbi.nlm.nih.gov/25750063/

2122

Hou L, Savage SA, Blaser MJ, et al. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(11):3103–9. https://pubmed.ncbi.nlm.nih.gov/19861514/

2123

Gu Y, Honig LS, Schupf N, et al. Mediterranean diet and leukocyte telomere length in a multi-ethnic elderly population. Age (Dordr). 2015;37(2):9758. https://pubmed.ncbi.nlm.nih.gov/25750063/

2124

García-Calzón S, Moleres A, Martínez-González MA, et al. Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population. Clin Nutr. 2015;34(4):694–9. https://pubmed.ncbi.nlm.nih.gov/25131600/

2125

Zainabadi K. A brief history of modern aging research. Exp Gerontol. 2018;104:35–42. https://pubmed.ncbi.nlm.nih.gov/29355705/

2126

Zainabadi K. A brief history of modern aging research. Exp Gerontol. 2018;104:35–42. https://pubmed.ncbi.nlm.nih.gov/29355705/

2127

Strong R, Miller RA, Antebi A, et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an a-glucosidase inhibitor or a Nrf2-inducer. Aging Cell. 2016;15(5):872–84. https://pubmed.ncbi.nlm.nih.gov/27312235/

2128

Gebreslassie M, Sampaio F, Nystrand C, Ssegonja R, Feldman I. Economic evaluations of public health interventions for physical activity and healthy diet: a systematic review. Prev Med. 2020;136:106100. https://pubmed.ncbi.nlm.nih.gov/32353572/

2129

Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128. https://pubmed.ncbi.nlm.nih.gov/23245604/

2130

Mokdad AH, Ballestros K, Echko M, et al. The state of US health, 1990–2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319(14):1444–72. https://pubmed.ncbi.nlm.nih.gov/29634829/

2131

Afshin A, Sur PJ, Fay KA, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393(10184):1958–72. https://pubmed.ncbi.nlm.nih.gov/30954305/

2132

Gebreslassie M, Sampaio F, Nystrand C, Ssegonja R, Feldman I. Economic evaluations of public health interventions for physical activity and healthy diet: a systematic review. Prev Med. 2020;136:106100. https://pubmed.ncbi.nlm.nih.gov/32353572/

2133

Das P, Samarasekera U. The story of GBD 2010: a “super-human” effort. Lancet. 2012;380(9859):2067–70. https://pubmed.ncbi.nlm.nih.gov/23259158/

1 ... 306 307 308 309 310 311 312 313 314 ... 510
Перейти на страницу: